215 related articles for article (PubMed ID: 33843158)
1. Weathering the storm: COVID-19 infection in patients with hematological malignancies.
Wang LQ; Tan Su Yin E; Wei GQ; Hu YX; Nagler A; Huang H
J Zhejiang Univ Sci B; 2020 Dec.; 21(12):921-939. PubMed ID: 33843158
[TBL] [Abstract][Full Text] [Related]
2. Convalescent hyperimmune plasma for chemo-immunotherapy induced immunodeficiency in COVID-19 patients with hematological malignancies.
Ferrari S; Caprioli C; Weber A; Rambaldi A; Lussana F
Leuk Lymphoma; 2021 Jun; 62(6):1490-1496. PubMed ID: 33461387
[TBL] [Abstract][Full Text] [Related]
3. Clinical Characteristics and Outcomes of COVID-19 in Turkish Patients with Hematological Malignancies.
Civriz Bozdağ S; Cengiz Seval G; Yönal Hindilerden İ; Hindilerden F; Andıç N; Baydar M; Aydın Kaynar L; Toprak SK; Göksoy HS; Balık Aydın B; Demirci U; Can F; Özkocaman V; Gündüz E; Güven ZT; Özkurt ZN; Demircioğlu S; Beksaç M; İnce İ; Yılmaz U; Eroğlu Küçükdiler H; Abishov E; Yavuz B; Ataş Ü; Mutlu YG; Baş V; Özkalemkaş F; Üsküdar Teke H; Gürsoy V; Çelik S; Çiftçiler R; Yağcı M; Topçuoğlu P; Çeneli Ö; Abbasov H; Selim C; Ar MC; Yücel OK; Sadri S; Albayrak C; Demir AM; Güler N; Keklik M; Terzi H; Doğan A; Yegin ZA; Kurt Yüksel M; Sadri S; Yavaşoğlu İ; Beköz HS; Aksu T; Maral S; Erol V; Kaynar L; İlhan O; Bolaman AZ; Sevindik ÖG; Akyay A; Özcan M; Gürman G; Ünal Ş; Yavuz Y; Diz Küçükkaya R; Özsan GH
Turk J Haematol; 2022 Feb; 39(1):43-54. PubMed ID: 34521187
[TBL] [Abstract][Full Text] [Related]
4. Managing and treating COVID-19 in patients with hematological malignancies: a narrative review and expert insights.
Ng HJ; Alata MK; Nguyen QT; Huynh Duc Vinh P; Tan JY; Wong CL
Clin Exp Med; 2024 Jun; 24(1):119. PubMed ID: 38833206
[TBL] [Abstract][Full Text] [Related]
5. Should we screen patients with hematologic malignancies for COVID-19?
Rassy E; Khoury-Abboud RM; Ibrahim N; Assi T; Samra B; Hanna C; Karak FE; Ghosn M
Hematol Oncol; 2020 Dec; 38(5):648-653. PubMed ID: 32779823
[TBL] [Abstract][Full Text] [Related]
6. Clinical characteristics, therapeutic management, and prognostic factors of adult COVID-19 inpatients with hematological malignancies.
Wu Y; Chen W; Li W; Zhao M; Wei Q; Zhang X; Mei H; Wang Y; Hu Y
Leuk Lymphoma; 2020 Dec; 61(14):3440-3450. PubMed ID: 32840399
[TBL] [Abstract][Full Text] [Related]
7. COVID-19 in patients with cancer: Risks and precautions.
Razavi A; Hamblin MR; Rezaei N
Am J Emerg Med; 2021 Oct; 48():357-360. PubMed ID: 33546958
[TBL] [Abstract][Full Text] [Related]
8. Imaging of Hematological Patients in the Era of COVID-19.
Eshet Y; Avigdor A; Kedmi M; Tau N
Acta Haematol; 2022; 145(3):267-274. PubMed ID: 35100592
[TBL] [Abstract][Full Text] [Related]
9. Risk factors and outcomes of COVID-19 in adult patients with hematological malignancies: A single-center study showing lower than expected rates of hospitalization and mortality.
Aumann S; Tsubary U; Nachmias B; Ben Yehuda D; Lavie D; Goldschmidt N; Vainstein V; Libster D; Saban R; Shaulov A; Israel S; Avni B; Grisariu S; Bdolah-Amram T; Gatt M; Zimran E
Eur J Haematol; 2023 Jul; 111(1):135-145. PubMed ID: 37096337
[TBL] [Abstract][Full Text] [Related]
10. Gene signature and immune cell profiling by high-dimensional, single-cell analysis in COVID-19 patients, presenting Low T3 syndrome and coexistent hematological malignancies.
Sciacchitano S; De Vitis C; D'Ascanio M; Giovagnoli S; De Dominicis C; Laghi A; Anibaldi P; Petrucca A; Salerno G; Santino I; Amodeo R; Simmaco M; Napoli C; Tafuri A; Di Napoli A; Sacconi A; Salvati V; Ciliberto G; Fanciulli M; Piaggio G; de Latouliere L; Ricci A; Mancini R
J Transl Med; 2021 Apr; 19(1):139. PubMed ID: 33794925
[TBL] [Abstract][Full Text] [Related]
11. [New aspects of myeloproliferative neoplasms: COVID-19 and myeloproliferative neoplasms].
Shide K
Rinsho Ketsueki; 2022; 63(6):647-654. PubMed ID: 35831201
[TBL] [Abstract][Full Text] [Related]
12. Long and persistent COVID-19 in patients with hematologic malignancies: from bench to bedside.
Laracy JC; Kamboj M; Vardhana SA
Curr Opin Infect Dis; 2022 Aug; 35(4):271-279. PubMed ID: 35849516
[TBL] [Abstract][Full Text] [Related]
13. Covid-19 in patients with hematological and solid cancers at a Comprehensive Cancer Center in Germany.
Shoumariyeh K; Biavasco F; Ihorst G; Rieg S; Nieters A; Kern WV; Miething C; Duyster J; Engelhardt M; Bertz H
Cancer Med; 2020 Nov; 9(22):8412-8422. PubMed ID: 32931637
[TBL] [Abstract][Full Text] [Related]
14. Clinical challenges in cancer patients with COVID-19: Aging, immunosuppression, and comorbidities.
Wang L; Sun Y; Yuan Y; Mei Q; Yuan X
Aging (Albany NY); 2020 Nov; 12(23):24462-24474. PubMed ID: 33232275
[TBL] [Abstract][Full Text] [Related]
15. Comorbidities and mortality rate in COVID-19 patients with hematological malignancies: A systematic review and meta-analysis.
Naimi A; Yashmi I; Jebeleh R; Imani Mofrad M; Azimian Abhar S; Jannesar Y; Heidary M; Pakzad R
J Clin Lab Anal; 2022 May; 36(5):e24387. PubMed ID: 35385130
[TBL] [Abstract][Full Text] [Related]
16. COVID-19 and seasonal influenza: a comparative analysis in patients with hematological malignancies.
Modemann F; Niederwieser C; Weisel K; Bokemeyer C; Fiedler W; Ghandili S
Leuk Lymphoma; 2022 Mar; 63(3):664-671. PubMed ID: 34668809
[TBL] [Abstract][Full Text] [Related]
17. Human and novel coronavirus infections in children: a review.
Rajapakse N; Dixit D
Paediatr Int Child Health; 2021 Feb; 41(1):36-55. PubMed ID: 32584199
[TBL] [Abstract][Full Text] [Related]
18. Pathogenesis-directed therapy of 2019 novel coronavirus disease.
Stratton CW; Tang YW; Lu H
J Med Virol; 2021 Mar; 93(3):1320-1342. PubMed ID: 33073355
[TBL] [Abstract][Full Text] [Related]
19. Clinical characteristics of four cancer patients with SARS-CoV-2 infection in Wuhan, China.
Song SH; Chen TL; Deng LP; Zhang YX; Mo PZ; Gao SC; Hu WJ; Xiong Y; Ma ZY
Infect Dis Poverty; 2020 Jul; 9(1):82. PubMed ID: 32616030
[TBL] [Abstract][Full Text] [Related]
20. COVID-19 in Immunocompromised Cancer Patients: A Case Series and Review of the Literature.
Patel RH; Vanaparthy R; Greene JN
Cancer Control; 2021; 28():10732748211044361. PubMed ID: 34579537
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
